P., Yang, B
2.2 Key Patent Expiry Dates and Early Launches For GLP-1 drugs, patent timing has played a critical role: Indian government and ICMR documents note that, as a concrete milestone, the core patent for semaglutide expired on March 20, 2026, triggering immediate generic launches and a sharp price drop across India.[4] According to Business Standard, more than 40 Indian drugmakers including Sun Pharma, Dr
However, its safety profile is well-understood from clinical trials (in both women and men) and years of research
The loophole is Section 503B of the Federal Food, Drug, and Cosmetic Act, which enables compounding facilities to produce knockoff versions of drugs that are in shortage
The specific brain regions in the hindbrain that mediate GLP-1R mediated suppression of food intake are currently being examined
These medications: Increase satiety Reduce appetite Slow digestion However, these treatments require injections, medical supervision, and ongoing use
